Atlas Trials

Childhood Mixed Glioma

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Childhood Mixed Glioma

RecordFirmDate
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas (NCT01514201)National Cancer Institute (NCI)2012-02-01
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma (NCT01462695)National Cancer Institute (NCI)2012-01-01
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01088763)National Cancer Institute (NCI)2010-03-01
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors (NCT01076530)National Cancer Institute (NCI)2010-02-01
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma (NCT00994500)National Cancer Institute (NCI)2009-08-01
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors (NCT00946335)National Cancer Institute (NCI)2009-07-01
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors (NCT00100880)National Cancer Institute (NCI)2004-11-01
Cilengitide in Treating Children With Refractory Primary Brain Tumors (NCT00063973)National Cancer Institute (NCI)2003-07-01
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors (NCT00052780)National Cancer Institute (NCI)2002-10-01

Track Childhood Mixed Glioma automatically

Every clearance here is in the API, with alerts when new ones post.